Markets:

Overview

News

Currencies

International

Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.450 +0.150 (+2.83%)

Delayed Quote Updated: 12:54 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Mid-Day Market Update: Nasdaq Turns Higher; Vocera Communications Shares Surge ↗

January 06, 2022

Midway through trading Thursday, the Dow traded down 0.34% to 36,284.59 while the NASDAQ rose 0.18% to 15,127.00. The S&P, however, rose 0.07% to 4,703.93. The U.S. has the...

Via Benzinga

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Agreements Totaling $11.5M for Gross Proceeds

January 06, 2022

Via Investor Brand Network

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 06, 2022

Gainers Freeline Therapeutics (NASDAQ:FRLN) stock increased by 58.1% to $3.1 during Thursday's pre-market session. The company's market cap stands at $111.0...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 06, 2022

Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

23 Stocks Moving in Thursday's Pre-Market Session ↗

January 06, 2022

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited...

Via Benzinga

50 Biggest Movers From Yesterday ↗

January 06, 2022

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 10, 2021

Gainers Quoin Pharmaceuticals (NASDAQ:

Via Benzinga

CNS Pharmaceuticals Announces Committee Approval of Pivotal Berubicin Study ↗

December 03, 2021

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central...

Via Benzinga

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Switzerland Ethics Committee Approval of Pivotal Berubicin Study

December 02, 2021

Via Investor Brand Network

CNS Pharmaceuticals Announces Participation at Upcoming Virtual Investor Roundtable ↗

November 17, 2021

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Roundtable

November 16, 2021

Via Investor Brand Network

JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th

November 04, 2021

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating...

From JTC Team, LLC

Via AccessWire

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Berubicin’s Impressive Potential in Syndicated Broadcast

October 11, 2021

Via Investor Brand Network

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 07, 2021

Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 20.46% to $0.8 during Thursday's pre-market session. The company's market cap stands at $68.5 million...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 30, 2021

Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Group of Patients in Potentially Pivotal Trial

September 30, 2021

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 14, 2021

Gainers Xeris Pharmaceuticals (NASDAQ:XERS

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 13, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 29, 2021

Gainers Brickell Biotech (NASDAQ:BBI) stoc...

Via Benzinga

Want to Buy CNS Pharmaceuticals (NASDAQ: CNSP) Stock? Read This First. ↗

June 29, 2021

CNS Pharmaceuticals (NASDAQ: CNSP) is a pre-clinical biotech company focusing on treatments for brain tumors. The firm holds the exclusive worldwide license for its main...

Via Benzinga

Global Brain Tumor Diagnosis & Treatment Market Could Exceed $880 Million By 2027

June 29, 2021

Via FinancialNewsMedia

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.